Rchr
J-GLOBAL ID:202401008412345394   Update date: Nov. 18, 2024

Tanaka Ryota

タナカ リョウタ | Tanaka Ryota
Affiliation and department:
Job title: Associate Professor
Research theme for competitive and other funds  (8):
  • 2024 - 2028 Clinical pharmacology studies to explore the optimal therapeutic strategy of novel antibody agents in systemic lupus erythematosus
  • 2022 - 2025 ゲノム・オミックス情報を駆使した薬物動態関連バイオマーカーの網羅的探索研究
  • 2022 - 2025 Development of useful new biomarkers to predict the severity and prognosis of vasculitis syndrome
  • 2019 - 2024 術後疼痛の症状マネジメントに用いる除痛アルゴリズムと評価指標の構築
  • 2020 - 2023 Population pharmacokinetic analysis of anti-infective drugs considering clearance with/without continuous renal replacement therapy in intensive care unit patients
Show all
Papers (100):
  • Matthijs W van Hoogdalem, Ryota Tanaka, Trevor N Johnson, Alexander A Vinks, Tomoyuki Mizuno. Development and verification of a full physiologically-based pharmacokinetic model for sublingual buprenorphine in healthy adult volunteers that accounts for nonlinear bioavailability. Drug metabolism and disposition: the biological fate of chemicals. 2024
  • 田中 遼大. 【疑問を解決!挑戦!薬物動態Quiz】妊婦・授乳婦編 妊婦への有益性投与の考え方. 調剤と情報. 2024. 30. 6. 785-788
  • 田中 遼大. 【疑問を解決!挑戦!薬物動態Quiz】妊婦・授乳婦編 授乳中患者の服薬継続可否. 調剤と情報. 2024. 30. 6. 790-794
  • Matthijs W van Hoogdalem, Ryota Tanaka, Khaled Abduljalil, Trevor N Johnson, Scott L Wexelblatt, Henry T Akinbi, Alexander A Vinks, Tomoyuki Mizuno. Forecasting Fetal Buprenorphine Exposure through Maternal-Fetal Physiologically Based Pharmacokinetic Modeling. Pharmaceutics. 2024. 16. 3
  • Ayako Oda, Yosuke Suzuki, Haruki Sato, Teruhide Koyama, Masahiro Nakatochi, Yukihide Momozawa, Ryota Tanaka, Hiroyuki Ono, Ryosuke Tatsuta, Tadasuke Ando, et al. Evaluation of the usefulness of plasma 4β-hydroxycholesterol concentration normalized by 4α-hydroxycholesterol for accurate CYP3A phenotyping. Clinical and translational science. 2024. 17. 3. e13768
more...
MISC (1):
  • 田中 遼大, 鈴木 陽介, 渡邊 博志, 藤岡 孝志, 龍田 涼佑, 丸山 徹, 伊東 弘樹. 末期腎不全患者におけるタクロリムスの血中濃度に及ぼす遺伝的要因と副甲状腺ホルモンの影響. 臨床薬理. 2020. 51. Suppl. S324-S324
Education (3):
  • 2011 - 2014 Kumamoto University Graduate School of Pharmaceutical Sciences Division of Pharmaceutical Education Course of Medicinal Sciences
  • 2009 - 2011 Kumamoto University Graduate School of Pharmaceutical Sciences Division of Pharmaceutical Education Course of Medicinal Sciences
  • 2005 - 2009 Kumamoto University School of Pharmacy
Work history (3):
  • 2020/03 - 現在 Oita University Hospital Department of Clinical Pharmacy Associate Professor & Deputy Director
  • 2022/04 - 2024/03 Cincinnati Children's Hospital Medical Center Division of Translational & Clinical Pharmacology Visiting Research Scientist
  • 2014/04 - 2020/02 Oita University Hospital Department of Clinical Pharmacy Pharmacist
Awards (8):
  • 2022/03 - 日本薬学会 2021 Top Reviewer Award for YAKUGAKU ZASSHI
  • 2021/05 - 日本化学療法学会 第69回日本化学療法学会総会学術奨励賞 発熱性好中球減少症の有無がバンコマイシンの小児薬物動態に与える影響
  • 2019/07 - 日本臨床薬理学会 第4回日本臨床薬理学会九州・沖縄地方会優秀発表賞 末期腎不全患者における移植後アルブミン翻訳後修飾体の変動評価
  • 2018/05 - 日本TDM学会 第35回日本TDM学会・学術大会優秀演題賞 UPLC-MS/MSを用いた総・遊離型ダプトマイシンの高感度同時定量法の開発
  • 2016/10 - 日本化学療法学会 第64回日本化学療法学会西日本支部 活性化委員会特別賞(臨床) LC-MS/MSを用いた総・遊離型イトラコナゾールの血中未変化体および活性代謝物の高感度同時定量法の確立
Show all
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page